Abdullah Alswied, MD

PhD, University of Oxford
MS, University of Liverpool
MD, King Faisal University

Dr. Alswied completed his medical degree at King Faisal University in Saudi Arabia, followed by advanced studies in the UK, earning a Master's from the University of Liverpool and a Ph.D. in Physiology, Anatomy, and Genetics from the University of Oxford, with research focused on calcium signaling in mast cells. He continued his training in the U.S. with a residency in Anatomic and Clinical Pathology at the University of Arizona, where he served as Chief Resident.

Dr. Alswied completed a fellowship in Transfusion Medicine at the NIH, where he also earned a Cellular Therapies Certificate from the AABB and received the AABB Future Leader Scholarship Award. His research spans transfusion medicine, cellular therapies, immunohematology, and optimizing apheresis for cellular therapy. He has authored multiple peer-reviewed publications and presented his research at national and international conferences. Now at the NIH Clinical Center, Dr. Alswied advances transfusion medicine and cellular engineering through clinical practice and research.

Boothby A, Tanner M, Alswied A, Youngs D, Bribiesca Rodriguez J, Bikkani T, Cha N, Gernsheimer T, Gimferrer G, Hess J, Sokol-Hessner L, Marivada S, Nash M, Flegel W, Vassallo R, Stroncek D, Tsang H, Panch S. "Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients." Blood Advances 8(17): 4689-4699, 2024.

Alswied A, Daniel D, Chen LN, West-Mitchell KA. "CD34+ cell yield among healthy donors: Large-scale model development and validation." Journal of Clinical Apheresis 39(3): e22135, 2024.

Alswied A, Hassan S, Rai H, Flegel W. "Neutrophil antigen antibodies affect engraftment and secondary graft failure in hematopoietic progenitor cell transplantation." Transfusion 64(6): 1050-1058, 2024.

Alqahtani T, Alswied A, Sun D. "Selective antitumor activity of datelliptium toward medullary thyroid carcinoma by downregulating RET transcriptional activity." Cancers 13(13): 3288, 2021.

Alswied A, Rehman A, Lai LW, Duran J, Sardar M, Proytcheva MA. "Rare monosomy 7 and deletion 7p at diagnosis of chronic myeloid leukemia in accelerated phase." Cancer Genetics 252: 111-114, 2021.

Gravbrot N, Brasiliense LBC, Alswied A, Sun B, Lemole GM Jr. "Multiple extra-axial cavernous hemangiomas: rare entity." World Neurosurgery 130: 364-368, 2019.

Al-Hariri MT, Eldin TG, Hashim T, Chathoth S, Alswied A. "Propolis modulates inflammatory mediators and improves histopathology in male rats with L-arginine-induced acute pancreatitis." Sultan Qaboos University Medical Journal 19(2): e103, 2019.

Alswied A, Parekh AB. "Ca2+ influx through store-operated calcium channels replenishes the functional phosphatidylinositol 4,5-bisphosphate pool used by cysteinyl leukotriene type I receptors." Journal of Biological Chemistry 290(49): 29555-29566, 2015.

Flanagan PK, Chiewchengchol D, Wright HL, Edwards SW, Alswied A, Satsangi Subramanian S, Rhodes JM, Campbell BJ. "Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D." Inflammatory Bowel Diseases 21(7): 1499-1510, 2015.

Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, Knight P, Codling C, Marchesi JR, Winstanley C, Hall N, Rhodes JM, Campbell BJ. "Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer." Gut 63(5): 761-770, 2014.